Abstract:Abstract Introduction In the absence of reversible etiology, central sleep apnea (CSA) may be treated with positive airway pressure (CPAP or BPAP), adaptive servo-ventilation, or supplemental oxygen. In 2017, a transvenous phrenic nerve stimulator (PNS), the remedē SystemTM, was FDA-approved for moderate-to-severe CSA. Five-year outcomes data confirmed the device’s sustained efficacy, with improvements in symptoms, apnea-hypopnea index(AHI), and central apnea index(CAI). While the device effectively treats CSA, unrecognized upper airway obstruction may hinder clinical success. This case report describes a patient whose polysomnography (PSG) suggested candidacy for PNS; however, his airway collapsibility led to severe obstructive sleep apnea(OSA), unmasked after PNS implantation. Report of case(s) Our patient is a 74-year-old with longstanding severe CSA and chronic insomnia. He has a history of spasmodic dysphonia status post recurrent laryngeal nerve ablation. His unilateral vocal fold paralysis was followed by injection medialization for voice augmentation. He is also an asymptomatic carrier of myotonic dystrophy(MD), identified after his grandchild was diagnosed with MD. He presented to our institution for daytime sleepiness, disrupted sleep and snoring with complaints of PAP intolerance. PSG revealed an AHI4% of 49.1 events/hour with 0 obstructive apneas, 89 central apneas, and 53 unclassified hypopneas. Transthoracic echocardiogram was unremarkable. Pulmonary function tests were normal without evidence of neuromuscular weakness or extrathoracic obstruction. He underwent PNS implantation. Postoperatively, the patient continued endorsing unrefreshed sleep. His PNS titration study demonstrated prolonged flow limitation and an AHI4% of 35.2 events/hour with frequent obstructive events. He is now using a mandibular advancement device (MAD) with the PNS. Conclusion This case highlights the impact of upper airway collapsibility on PNS treatment response. Although our patient’s history may have indicated greater susceptibility to airway collapse, preoperative PSG did not reveal unequivocal OSA. However, frequent obstructive hypopneas were unmasked after PNS implantation. This patient’s upper airway collapse was underrepresented on PSG, and increased negative intrathoracic pressure during the PNS titration may have worsened the severity. Since differentiating central from obstructive hypopneas can be challenging, PNS may not be ideal for CSA patients with increased hypopnea burdens. If OSA emerges postoperatively, adjuncts like MAD, CPAP, or hypoglossal nerve stimulation may stabilize the upper airway. Support (if any)

1145 Stride Along with Stridor in the Setting of CSA: An Unusual Presentation of Pediatric Cervicomedullary Ganglioma

1149 Unravelling the Mysteries of Pediatric Central Sleep Apnea (CSA): A Unique Case Report

1209 A Case of Morquio Syndrome Presenting as Respiratory Failure Due to Severe OSA and Successful Long-term Treatment

Central sleep apnoea as an initial presentation of a posterior fossa juvenile pilocytic astrocytoma

The relationship between Chiari 1.5 malformation and sleep-related breathing disorders on polysomnography

Acute Myeloblastic Leukemia with Initial Manifestations in the Central Airway.

1173 Unmasking Severe OSA After Transvenous Phrenic Nerve Stimulation for Central Sleep Apnea

A Veiled Lymphatic Malformation: Stridor in a Child

1223 Central sleep apnea and Chiari 1 malformation in a pediatric patient with Klippel-Feil sequence

Adenoidectomy in a child with Crouzon syndrome complicated with severe obstructive sleep apnea: Case report and review of literature

Type one chiari malformation as a cause of central sleep apnea and hypoventilation in children

1154 Life Threatening Obstructive Sleep Apnea in a Patient with Joubert Syndrome and Pierre Robin Sequence

1172 Hoops by Day, Ventilator by Night

The anesthetic management of a child with ohtahara syndrome and severe stridor: a case report

1227 Spinal Stenosis as a Rare Cause of Central Sleep Apnea

Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea in a Young Child With Down Syndrome

A Case of Profound Obstructive Sleep Apnea Secondary to an Unrecognized Lingual Angiomyxoma

1163 Central Sleep Apnea: A Possible Rare Adverse Effect of Vagus Nerve Stimulation

Long-Term Outcomes of Airway Management in 6 Children With Campomelic Dysplasia

1229 Dual Neurostimulator Therapy for CSA and OSA in an Elderly Gentleman with Native Pacemaker

1220 Polysomnography in Children with Joubert Syndrome